Comparative Effects of Moxonidine on Bone Metabolism, Vascular and Cellular Aging in Hypertensive Postmenopausal Women (COMPASS)
Comparative Effects of Moxonidine and Bisoprolol on Bone Metabolism, Vascular and Cellular Markers of Aging, Blood Pressure in Hypertensive Postmenopausal Women (COMPASS)
Sponsor: National Research Center for Preventive Medicine
Listed as NCT02355821, this NA trial focuses on Arterial Hypertension and Osteopenia and remains completed. Sponsored by National Research Center for Preventive Medicine, it has been updated 13 times since 2015, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 8 earlier versions
-
Oct 2021 — Dec 2022 [monthly]
Completed NA
-
Jan 2021 — Oct 2021 [monthly]
Completed NA
-
Sep 2020 — Jan 2021 [monthly]
Completed NA
-
Nov 2018 — Sep 2020 [monthly]
Completed NA
-
Aug 2018 — Nov 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Dec 2017 [monthly]
Recruiting NA
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Research Center for Preventive Medicine
For direct contact, visit the study record on ClinicalTrials.gov .